HPGC Renmintongtai Pharmaceutical Corp Cash Flow Conversion Efficiency

Latest as of September 2025: -0.063x

HPGC Renmintongtai Pharmaceutical Corp cash flow conversion efficiency. Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

Cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View HPGC Renmintongtai Pharmaceutical Corp share price for real-time trading data and today's change.

HPGC Renmintongtai Pharmaceutical Corp Cash Flow Conversion Ratio Explained

HPGC Renmintongtai Pharmaceutical Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency. Also see 600829 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Odfjell SE OL:ODF	0.078x
INDIA SHELTER FINANCE CORPORATION LIMITED NSE:INDIASHLTR	-0.149x
Shenzhen Rapoo Technology SHE:002577	0.026x
Guizhou Zhenhua E chem Inc SHG:688707	-0.026x
PAR Technology Corporation NYSE:PAR	-0.012x
Niutech Environment Technology Corp SHG:688309	0.063x
Zhongyin Babi Food Co. Ltd. SHG:605338	0.111x
Sparebank 1 Ringerike Hadeland OL:RING	0.191x

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. Review HPGC Renmintongtai Pharmaceutical Corp (600829) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.01 Billion ≈ $441.19 Million	CN¥299.98 Million ≈ $43.90 Million	0.099x	+148.33%
2024-12-31	CN¥2.88 Billion ≈ $421.60 Million	CN¥115.44 Million ≈ $16.89 Million	0.040x	-66.89%
2023-12-31	CN¥2.75 Billion ≈ $402.61 Million	CN¥332.99 Million ≈ $48.73 Million	0.121x	-3.02%
2022-12-31	CN¥2.46 Billion ≈ $360.36 Million	CN¥307.33 Million ≈ $44.97 Million	0.125x	+217.79%
2021-12-31	CN¥2.20 Billion ≈ $321.82 Million	CN¥-233.00 Million ≈ $-34.10 Million	-0.106x	-2188.91%
2020-12-31	CN¥1.99 Billion ≈ $291.54 Million	CN¥-9.22 Million ≈ $-1.35 Million	-0.005x	+97.92%
2019-12-31	CN¥1.85 Billion ≈ $270.31 Million	CN¥-411.60 Million ≈ $-60.23 Million	-0.223x	-196.07%
2018-12-31	CN¥1.58 Billion ≈ $231.19 Million	CN¥366.45 Million ≈ $53.62 Million	0.232x	+168.84%
2017-12-31	CN¥1.61 Billion ≈ $235.89 Million	CN¥139.07 Million ≈ $20.35 Million	0.086x	+208.97%
2016-12-31	CN¥1.65 Billion ≈ $241.12 Million	CN¥46.01 Million ≈ $6.73 Million	0.028x	-88.10%
2015-12-31	CN¥1.42 Billion ≈ $208.27 Million	CN¥333.99 Million ≈ $48.87 Million	0.235x	+28.70%
2014-12-31	CN¥2.15 Billion ≈ $315.05 Million	CN¥392.58 Million ≈ $57.45 Million	0.182x	+360.00%
2013-12-31	CN¥2.26 Billion ≈ $330.33 Million	CN¥-158.31 Million ≈ $-23.17 Million	-0.070x	-172.98%
2012-12-31	CN¥2.31 Billion ≈ $337.41 Million	CN¥221.57 Million ≈ $32.42 Million	0.096x	+271.75%
2011-12-31	CN¥1.94 Billion ≈ $283.25 Million	CN¥-108.30 Million ≈ $-15.85 Million	-0.056x	-159.69%
2010-12-31	CN¥1.74 Billion ≈ $254.43 Million	CN¥162.99 Million ≈ $23.85 Million	0.094x	-65.32%
2009-12-31	CN¥1.66 Billion ≈ $242.41 Million	CN¥447.82 Million ≈ $65.53 Million	0.270x	+776.00%
2008-12-31	CN¥1.65 Billion ≈ $241.27 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.040x	-129.42%
2007-12-31	CN¥1.41 Billion ≈ $205.71 Million	CN¥191.10 Million ≈ $27.96 Million	0.136x	-22.95%
2006-12-31	CN¥1.08 Billion ≈ $158.53 Million	CN¥191.13 Million ≈ $27.97 Million	0.176x	-49.94%
2005-12-31	CN¥888.23 Million ≈ $129.98 Million	CN¥313.04 Million ≈ $45.81 Million	0.352x	+504.14%
2004-12-31	CN¥1.04 Billion ≈ $152.24 Million	CN¥60.69 Million ≈ $8.88 Million	0.058x	-54.38%
2003-12-31	CN¥560.39 Million ≈ $82.00 Million	CN¥71.65 Million ≈ $10.48 Million	0.128x	-47.23%
2002-12-31	CN¥526.17 Million ≈ $77.00 Million	CN¥127.49 Million ≈ $18.66 Million	0.242x	+720.86%
2001-12-31	CN¥501.11 Million ≈ $73.33 Million	CN¥14.79 Million ≈ $2.16 Million	0.030x	-77.75%
2000-12-31	CN¥466.36 Million ≈ $68.24 Million	CN¥61.85 Million ≈ $9.05 Million	0.133x	-3.81%
1999-12-31	CN¥422.13 Million ≈ $61.77 Million	CN¥58.21 Million ≈ $8.52 Million	0.138x	+44.85%
1998-12-31	CN¥430.69 Million ≈ $63.02 Million	CN¥41.00 Million ≈ $6.00 Million	0.095x	--

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic

Market Cap

$734.85 Million

CN¥5.02 Billion CNY

Market Cap Rank

#9952 Global

#2585 in China

Share Price

CN¥8.66

Change (1 day)

-3.13%

52-Week Range

CN¥7.76 - CN¥17.72

All Time High

CN¥17.72